For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
VP, Technical - Regulatory Strategy
Sinan has worked in the EU regulatory system for more than a decade. At the EMA, he has served as a member of the Committee for Medicinal Products for Human Use (CMP), the Committee for Advanced Therapies (CAT), and the Scientific Advice Working Party (SAWP), and as a member and chair of CHMP’s Oncology Working Party (ONCWP). He also served as chief medical officer at the Danish Medicines Agency. He was responsible for the scientific evaluation of new cancer products, extension of indications, and national scientific advice. His experience covers oncology, hematology, rare diseases, advanced therapies, small molecules, monoclonal antibodies, and other protein-based products.